If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,990.00
Bid: 0.00
Ask: 2,250.00
Change: 0.00 (0.00%)
Spread: 270.00 (13.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,990.00
SUS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

10 Feb 2017 07:00

RNS Number : 5406W
S & U PLC
10 February 2017
 

 10th February 2017

 

 

S&U plc

("S&U", "the Company" or "the Group")

 

YEAR END TRADING UPDATE

 

 

S&U plc, the motor finance and specialist lender, today issues a trading update for the period from its Trading Statement of the 8th December 2016 to the Company's year-end on the 31st January 2017.

 

The Company is again pleased to announce that trading has remained strong and in line with market expectations; its final results will be announced on 28th March 2017.

 

Current Trading

 

Advantage Finance, our motor finance business, finished a record year very strongly. Cash collections in the period exceeded a buoyant 2016 by 31%, whilst both transaction numbers and loan advances comfortably beat last year. This year Advantage achieved 20,000 new transactions for the first time, beating the previous record by nearly 5,000 deals; it now has a record 43,000 live customers.

 

Loan quality remains good and, as reported in our last Trading Statement, is both stable and within our expectations. This fully justifies the additional £33million invested in the business in the year just ended.

 

Within the last quarter, Advantage has received confirmation of its full licence authorisation from the FCA and has continued to introduce further refinements to its renowned underwriting and book analysis capabilities. 

 

Aspen Bridging

 

As anticipated in December, our Aspen bridging finance operation has now received all necessary approvals, and we are pleased to announce it has now opened for business. We confidently expect a successful pilot over the next fifteen months.

 

Funding and Treasury

 

At the year end the Group has borrowings of £49m allowing good headroom within our total committed facilities of £85m. We anticipate concluding further loan facilities as our businesses require.

 

Dividend

 

The Group's current trading and future prospects have led to your Board approving a second interim dividend of 28p per ordinary share (2016: 23p). This will be payable on 17th March 2017 to holders on the share register on the 24th February 2017. Together with the first dividend paid in November of 24p per share this will total 52p per share against 43p last year and 36p two years ago. These increases are consistent with our aim of returning to twice covered dividends over time.

 

 

 

 

Commenting on the Group trading and outlook, Anthony Coombs, Chairman of S&U PLC said:

 

"Within a robust domestic economy, a stable regulatory environment and a competitive market, we are confident in the Group's ability to continue to grow at a consistent and sustainable rate, and in the shareholder value that implies."

For further information, please contact:

 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777

 

Broker & Financial Advisor

Chris Hardie Arden Partners 0207 614 5917

 

Media and Investor Relations

Ged Brumby Smithfield 0207 903 0674

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBLGDDISGBGRC
Date   Source Headline
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.